Monogram Technologies Inc. is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining 3D printing, advanced machine vision, AI and robotics. The Company's mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its FDA-cleared mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. It is also exploring other clinical and commercial applications for mBos with mVision navigation. Its mVision technology leverages AI-trained algorithms to track pre-identified objects in real-time.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement and Estimates

More financial data

Market Closed - Nasdaq Other stock markets 04:00:00 07/10/2025 HKT			5-day change	1st Jan Change
6.000 ^USD	-1.80%		-.--%	-

08/10/25	Zimmer Biomet Wraps Up Purchase of Orthopedic Robotics Group Monogram Technologies	MT
08/10/25	Monogram Technologies Inc.(NasdaqCM:MGRM) dropped from S&P TMI Index	CI

Market Cap	244M 211M 194M 182M 340M 23.17B 346M 2.29B 893M 11.28B 915M 895M 39.05B	P/E Ratio 2023	-5.61x	P/E Ratio 2024	-4.73x
Enterprise Value	228M 197M 182M 170M 319M 21.72B 324M 2.15B 837M 10.57B 857M 839M 36.6B	EV / Sales 2023	257,522,925x	EV / Sales 2024	-
Free-Float	64.74%	Yield 2023 *	-	Yield 2024	-

08/10/25	Zimmer Biomet Wraps Up Purchase of Orthopedic Robotics Group Monogram Technologies	MT
08/10/25	Monogram Technologies Inc.(NasdaqCM:MGRM) dropped from S&P TMI Index	CI
08/10/25	Monogram Technologies Inc. Announces Board Changes	CI
08/10/25	Zimmer Biomet Holdings, Inc. completed the acquisition of Monogram Technologies Inc..	CI
07/10/25	Zimmer Biomet Completes Acquisition of Monogram Technologies	MT
07/10/25	Zimmer Biomet completes acquisition of Monogram Technologies	RE
07/10/25	Monogram Technologies Inc.(NasdaqCM:MGRM) dropped from NASDAQ Composite Index	CI
07/10/25	Monogram Technologies Inc.(NasdaqCM:MGRM) dropped from Russell Microcap Growth Benchmark Index	CI
07/10/25	Monogram Technologies Inc.(NasdaqCM:MGRM) dropped from Russell 3000E Growth Benchmark	CI
07/10/25	Monogram Technologies Inc.(NasdaqCM:MGRM) dropped from Russell 3000E Growth Index	CI
07/10/25	Monogram Technologies Inc.(NasdaqCM:MGRM) dropped from Russell 3000E Index	CI
07/10/25	Monogram Technologies Inc.(NasdaqCM:MGRM) dropped from Russell Microcap Index	CI
07/10/25	Monogram Technologies Inc.(NasdaqCM:MGRM) dropped from Russell Microcap Growth Index	CI

30/07/25	Monogram Technologies Announces World's First Fully Autonomous Saw-Based Robotic Knee Replacement Surgery	AQ
29/07/25	Monogram Technologies Announces World’s First Fully Autonomous Saw-Based Robotic Knee Replacement Surgery	GL
29/07/25	Monogram Technologies Announces World’s First Fully Autonomous Saw-Based Robotic Knee Replacement Surgery	AQ
16/07/25	MONOGRAM TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Monogram Technologies Inc. - MGRM	BU
14/07/25	Zimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous Solutions	GL

Monogram Technologies Inc. Stock

Stocks

MGRM

US6097861081

Medical Equipment, Supplies & Distribution

Valuation: Monogram Technologies Inc.

Chart: Monogram Technologies Inc.

Latest news : Monogram Technologies Inc.

Last Transcript: Monogram Technologies Inc.

Analysts' recommendations: Monogram Technologies Inc.

Press Releases: Monogram Technologies Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Monogram Technologies Inc.

Latest insider transactions

Medical Devices & Implants

Financials

Company Profile

Income Statement and Estimates

1 year	2.66	6.42
3 years	1.53	6.55
5 years	1.53	48.99
10 years	1.53	48.99

Date	Insider	Type	Main position	Quantity	% Market Cap.
07/10/25	Richard van Kirk	Issuer sale	Director	7,000	0.0172%
07/10/25	Colleen Gray	Issuer sale	Director	8,000	0.0197%
07/10/25	Noel Knape	Issuer sale	Chief Financial Officer	411,385	1.0125%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MONOGRAM TECHNOLOGIES INC.	-1.80%	-.--%	+125.56%	+54.24%	244M
STRYKER CORPORATION	+2.15%	+2.14%	-17.25%	+6.35%	120B
SMITH & NEPHEW PLC	-0.31%	-1.22%	+3.56%	-9.29%	12.9B
GLAUKOS CORPORATION	+2.05%	+1.45%	+29.93%	+89.66%	7.44B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+1.87%	-4.66%	-46.88%	-70.47%	4.2B
DOUBLE MEDICAL TECHNOLOGY INC.	+2.06%	+4.10%	+11.98%	+33.22%	2.55B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	+5.46%	+10.04%	-15.76%	-14.88%	1.8B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	+1.67%	-5.73%	+5.08%	-11.03%	1.66B
L&C BIO CO.,LTD	-8.89%	-10.79%	+152.96%	+121.29%	1.37B
Average	+0.47%	+0.78%	+27.69%	+22.12%	16.87B
Weighted average by Cap.	+1.85%	+1.76%	-11.48%	+8.10%

	2023	2024
Net sales	0.36 0.32 0.29 0.27 0.51 34.69 0.52 3.43 1.34 16.89 1.37 1.34 58.47	-
Net income	-13.75M -11.87M -10.94M -10.24M -19.19M -1.31B -19.49M -129M -50.36M -636M -51.59M -50.49M -2.2B	-16.33M -14.1M -13M -12.16M -22.8M -1.55B -23.15M -153M -59.83M -755M -61.28M -59.97M -2.62B
Net Debt	-13.1M -11.31M -10.42M -9.76M -18.29M -1.24B -18.57M -123M -47.99M -606M -49.15M -48.11M -2.1B	-15.33M -13.24M -12.2M -11.42M -21.4M -1.46B -21.73M -144M -56.16M -709M -57.52M -56.29M -2.46B